Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars V Kessing

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Frontiers in Neuroscience|December 12, 2019
Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning ApproachSøren F V Nielsen, Kristoffer H Madsen, Maj Vinberg, et al.
Bipolar Disorders|June 22, 2016
Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective studyAnne S Jacoby, Klaus Munkholm, Maj Vinberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 11, 2013
Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trialKamilla W Miskowiak, Maj Vinberg, Ellen M Christensen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 30, 2024
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in bloodClara A Madsen, Miriam L Navarro, Betina Elfving, et al.
Bipolar Disorders|April 25, 2024
Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence mattersLakshmi N Yatham, Ayal Schaffer, Lars V Kessing, et al.
Trials|September 14, 2018
Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trialCaroline V Ott, Maj Vinberg, Christopher R Bowie, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 10, 2020
Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: a randomized controlled trialCaroline V Ott, Julian Macoveanu, Christopher R Bowie, et al.
Journal of Affective Disorders|December 7, 2020
Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorderCaroline V Ott, Ulla Knorr, Andreas Jespersen, et al.
Acta Neuropsychiatrica|April 6, 2026
Early health economic assessment of eLi<sub>12</sub>, a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hoursOle Köhler-Forsberg, Thea K Kjær, Andrew A Nierenberg, et al.
Trials|April 10, 2019
Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trialCaroline V Ott, Maj Vinberg, Christopher R Bowie, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Frontiers in Neuroscience|December 12, 2019
Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning ApproachSøren F V Nielsen, Kristoffer H Madsen, Maj Vinberg, et al.
Bipolar Disorders|June 22, 2016
Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective studyAnne S Jacoby, Klaus Munkholm, Maj Vinberg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 11, 2013
Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trialKamilla W Miskowiak, Maj Vinberg, Ellen M Christensen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 30, 2024
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in bloodClara A Madsen, Miriam L Navarro, Betina Elfving, et al.
Bipolar Disorders|April 25, 2024
Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence mattersLakshmi N Yatham, Ayal Schaffer, Lars V Kessing, et al.
Trials|September 14, 2018
Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trialCaroline V Ott, Maj Vinberg, Christopher R Bowie, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 10, 2020
Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: a randomized controlled trialCaroline V Ott, Julian Macoveanu, Christopher R Bowie, et al.
Journal of Affective Disorders|December 7, 2020
Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorderCaroline V Ott, Ulla Knorr, Andreas Jespersen, et al.
Acta Neuropsychiatrica|April 6, 2026
Early health economic assessment of eLi<sub>12</sub>, a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hoursOle Köhler-Forsberg, Thea K Kjær, Andrew A Nierenberg, et al.
Trials|April 10, 2019
Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trialCaroline V Ott, Maj Vinberg, Christopher R Bowie, et al.
Pageof 12